Novo Nordisk reportedly faces US congressional review for halting sales of long-acting insulin Levemir in the US
soul1987
发表于 2024-7-16 17:07:13
3132
0
0
Novo Nordisk is reportedly facing scrutiny from the US Congress for discontinuing the sale of long-acting insulin Levemir in the US.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- The US Congress is targeting inheritance preferences in the process of college enrollment and admission
- Two parties in the US Congress reach a $1.66 trillion spending agreement
- Lilly Ultra Long acting Insulin Phase III Clinical Success
- Ministry of Foreign Affairs: Countermeasures against US Congressman McGovern
- Novo Nordisk to invest 864 million Brazilian reals to renovate insulin factory in Brazil
- Novo Nordisk to invest 864 million Brazilian reals to renovate insulin factory in Brazil
- Tesla's market value evaporated by over 520 billion yuan overnight! The panic index surged by 23% at one point! Yellen warns US Congress
